A detailed history of Dsm Capital Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dsm Capital Partners LLC holds 7,721 shares of LLY stock, worth $6.22 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,721
Previous 101 7544.55%
Holding current value
$6.22 Million
Previous $78,000 8861.54%
% of portfolio
0.1%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $5.52 Million - $6.93 Million
7,620 Added 7544.55%
7,721 $6.99 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $11,844 - $15,845
20 Added 24.69%
101 $78,000
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $42,540 - $50,149
81 New
81 $47,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dsm Capital Partners LLC Portfolio

Follow Dsm Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsm Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dsm Capital Partners LLC with notifications on news.